mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-05 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
6e-05 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
7e-05 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
7e-05 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
7e-05 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
9e-05 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0001 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0001 |